Advanced search
Publication Cover
Postgraduate Medicine Volume 126, 2014 - Issue 3
Submit an article Journal homepage
64
Views
6
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes and Concomitant Disorders

Evidence-Based Practice Use of Incretin-Based Therapy in the Natural History of Diabetes

Stanley Schwartz Affiliate, Main Line Health System, Ardmore, PA; Emeritus, Clinical Associate Professor of Medicine, University of Pennsylvania, Philadelphia, PACorrespondence[email protected]
, MD
Pages 66-84 | Published online: 13 Mar 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Stanley S. Schwartz, Paul S. Jellinger & Mary E. Herman. (2016) Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile. Postgraduate Medicine 128:6, pages 609-619.
Read now
A. Brett Hauber, Hiep Nguyen, Joshua Posner, Iftekhar Kalsekar & James Ruggles. (2016) A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes. Current Medical Research and Opinion 32:2, pages 251-262.
Read now
Stanley Schwartz & Mary Herman. (2015) Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies. Postgraduate Medicine 127:5, pages 480-493.
Read now

Articles from other publishers (3)

Stanley S. Schwartz, Solomon Epstein, Barbara E. Corkey, Struan F.A. Grant, James R. GavinIIIIII & Richard B. Aguilar. (2016) The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care 39:2, pages 179-186.
Crossref
Archana R. Sadhu, Stanley S. Schwartz & Mary E. Herman. (2015) The Rationale for use of Incretins in the Management of new Onset Diabetes After Transplantation (NODAT). Endocrine Practice 21:7, pages 814-822.
Crossref
Javier Morales & Ludwig Merker. (2015) Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira). Advances in Therapy 32:5, pages 391-403.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.